4.3 Article

Clinical validation and utility of Chinese Eppendorf Itch Questionnaire in adults with chronic pruritus symptoms

期刊

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
卷 120, 期 1, 页码 492-500

出版社

ELSEVIER TAIWAN
DOI: 10.1016/j.jfma.2020.06.022

关键词

Pruritus; Surveys and questionnaires; Validation

资金

  1. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) pilot research grant
  2. Ministry of Science and Technology, Taiwan [MOST 105-2628-B-182-006]

向作者/读者索取更多资源

The Chinese version of the Eppendorf Itch Questionnaire (EIQ) has been validated for use in adult patients with chronic itch in outpatient settings. The questionnaire demonstrated good reliability and validity, with patients showing different responses to itch across various dermatoses. The multi-scale EIQ index was found to be more effective in distinguishing eczema-related itch from psoriasis or xerosis-related itch than the visual analogue scale alone.
Background: Pruritus, or itch, is a prevalent symptom causing profound health burden in many dermatological and non-dermatological disorders. Several itch questionnaires have been created to assess itch. Particularly, Eppendorf Itch Questionnaire (EIQ) is widely accepted since it encompasses various aspects of itch, including intensity, affects, coping behavior, and motivation to scratch. Methods: In a cross-sectional survey, we examined the validity, reliability and clinical utility of Traditional Chinese EIQ. Results: We administered the consensus version to 128 adults (median: 48.5 years, interquartile range [IQR]: 39-63) with active itch for more than 6 weeks at the Outpatient Clinics of three medical centers in Taiwan. Clinical diagnoses included psoriasis (N = 82), xerosis (N = 34), or other dermatitis (N = 12). Cronbach's alpha for each EIQ scale ranged 0.82 - 0.98, suggesting good to excellent internal consistency and reliability. Three EIQ scales significantly correlated with visual analogue scale (VAS) for itch intensity (P <= 0.001 for median test), supporting for its concurrent validity. None of EIQ scale was statistically correlated with Psoriasis Area Severity Index (PASI) scores in psoriasis patients, confirming its discriminant validity. Moreover, patients of different diagnoses had distinct responses to the multi-scale EIQ index, affording it a better clinical test (area-under-the-ROC curve [AUC]: 0.76, 95% CI: 0.63 - 0.90) than VAS alone (AUC: 0.42, 95%CI: 0.24-0.59) in distinguishing dermatitis/eczemarelated itch from psoriasis or xerosis-related itch. Conclusion: We demonstrated the reliability and validity of Chinese EIQ in adult patients with chronic itch at the outpatient setting. The study also revealed the diversified aspects of itch across patients with various dermatoses. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据